AG00GS7B

89213-87-6 | Atrial Natriuretic Peptide (1-28) (human) (trifluoroacetate salt)

Chemical structure of Atrial Natriuretic Peptide (1-28) (human) (trifluoroacetate salt), CAS 89213-87-6
AG00GS7B
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 89213-87-6
Catalog Number AG00GS7B(AGN-PC-0VONCE)
Chemical Name Atrial Natriuretic Peptide (1-28) (human) (trifluoroacetate salt)
IUPAC Name (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-19-(3-amino-3-oxopropyl)-49-benzyl-28-[(2S)-butan-2-yl]-31,40-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16-(hydroxymethyl)-22-methyl-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
InChI InChI=1S/C127H203N45O39S3/c1-9-64(6)99-121(209)150-52-94(182)151-65(7)100(188)155-76(34-35-91(129)179)109(197)167-85(56-174)104(192)149-53-96(184)153-78(43-62(2)3)102(190)148-54-97(185)154-89(119(207)164-82(48-92(130)180)114(202)169-86(57-175)116(204)163-81(46-67-23-14-11-15-24-67)113(201)158-73(27-18-39-143-125(135)136)107(195)166-84(122(210)211)47-68-30-32-69(178)33-31-68)60-213-214-61-90(171-118(206)88(59-177)170-117(205)87(58-176)168-108(196)74(28-19-40-144-126(137)138)156-106(194)72(26-17-38-142-124(133)134)157-112(200)79(44-63(4)5)161-101(189)70(128)55-173)120(208)162-80(45-66-21-12-10-13-22-66)103(191)147-50-93(181)146-51-95(183)152-71(25-16-37-141-123(131)132)105(193)160-77(36-42-212-8)110(198)165-83(49-98(186)187)115(203)159-75(111(199)172-99)29-20-41-145-127(139)140/h10-15,21-24,30-33,62-65,70-90,99,173-178H,9,16-20,25-29,34-61,128H2,1-8H3,(H2,129,179)(H2,130,180)(H,146,181)(H,147,191)(H,148,190)(H,149,192)(H,150,209)(H,151,182)(H,152,183)(H,153,184)(H,154,185)(H,155,188)(H,156,194)(H,157,200)(H,158,201)(H,159,203)(H,160,193)(H,161,189)(H,162,208)(H,163,204)(H,164,207)(H,165,198)(H,166,195)(H,167,197)(H,168,196)(H,169,202)(H,170,205)(H,171,206)(H,172,199)(H,186,187)(H,210,211)(H4,131,132,141)(H4,133,134,142)(H4,135,136,143)(H4,137,138,144)(H4,139,140,145)/t64-,65-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,99-/m0/s1
InChI Key NSQLIUXCMFBZME-MPVJKSABSA-N
MDL Number MFCD00076226
Molecular Formula C129H204F3N45O41S3
Molecular Weight 3194.4672
SMILES [H]N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@H](C(N[C@H](C(NCC(NCC(N[C@@H](CCCNC(N)=N)C(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@]([C@H](CC)C)([H])C(NCC(N[C@H](C(N[C@@H](CCC(N)=O)C(N[C@@H](CO)C(NCC(N[C@@H](CC(C)C)C(NCC1=O)=O)=O)=O)=O)=O)C)=O)=O)=O)=O)CC(O)=O)=O)CCSC)=O)=O)=O)=O)CC2=CC=CC=C2)=O)CSSC[C@H](N1)C(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(O)=O)CC3=CC=C(O)C=C3)=O)=O)CC4=CC=CC=C4)=O)=O)=O)=O)=O)=O)=O)=O)=O.FC(F)(C(O)=O)F
UNII GZ8FA500J0
Synonyms
alpha-atrial natriuretic peptide, human, alpha-hANP, alpha-human atrial natriuretic peptide, atrial natriuretic peptide precusor A, human, carperitide, natriuretic peptide precursor A, human, NPPA protein, human, Carperitide, alpha-Atriopeptin, 89213-87-6, SUN-4936, alpha-Human atriopeptin, Atriopeptin-28 (human), alpha-Atriopeptin (human), Human atriopeptin(1-28), UNII-GZ8FA500J0, Human atriopeptin(99-126), CCRIS 4930, Triopeptin (human alpha-component), alpha-Human atrial natriuretic hormone, Atrial natriuretic factor (99-126), GZ8FA500J0, Atriopeptin, anp 1-28, human, Atrial natriuretic factor (1-28) (human, porcine), Atriopeptins, Atriopeptin-33(rat), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-proline-5-de-L-arginine-17-L-methionine-, L-Seryl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine cyclic(7->23)-disulfide, L-Seryl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine cyclic(7-23)-disulfide, Auriculin (peptide), Carperitide [INN], Atrial natriuretic hormone, Atrial natriuretic peptides, Carperitide [USAN:INN], Natriuretic peptides, atrial, Atrial natriuretic peptide A, Atrial natriuretic polypeptide, cardionatrin I, ATRIAL NATRIURETIC FACTOR, alpha-hANP, anp, alpha-, human, NPPA protein, human, C127H203N45O39S3, Anp 1-28,human, atriopeptin (99-126), SCHEMBL218549, CHEMBL2104386, rat ANF (99-126), ALPHA-ANF(1-28)-HUMAN, CHEBI:135914, NSQLIUXCMFBZME-MPVJKSABSA-N, SUN 4936, ANF (Ser(99)-Tyr(126)), BDBM50230986, alpha-human atrial natriuretic peptide, AKOS024456845, atrial natriuretic factor 1-28, human, atrial natriuretic peptide 1-28, human, atrial natriuretic peptide human, 1-28, 85637-73-6, AN-35278, ANF (99-126), ANP-(99-126), LS-22207, Atrial natriuretic peptide-28 (human reduced), atrial natriuretic factor (Ser(99)-Tyr(126)), atrial natriuretic factor (1-28) (human, canine), atrial natriuretic peptide (1-28), human, porcine, Cardionatrin, Auriculin, Carperitide Acetate, Atrial Natriuretic Peptide, carperitide (recombinant), D03VNJ, ANP1-28,HUMAN, human atrial natriuretic peptide, Atrial Natriuretic Peptide human, ALPHA-ANF(1-28), HUMAN, ACN-057295, C127-H203-N45-O39-S3, 91917-63-4, ANP, ANF,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited